A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)

PURPOSE: We report our experience with the use of the matrix regenerating agent (RGTA) Cacicol(®) after reverse transepithelial all-surface laser ablation (ASLA)-SCHWIND to assess the safety, efficacy, pain, and epithelial healing. METHODS: Forty eyes of 20 myopic patients were prospectively recruit...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslanides, Ioannis M, Selimis, Vasilis D, Bessis, Nikolaos V, Georgoudis, Panagiotis N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404873/
https://www.ncbi.nlm.nih.gov/pubmed/25931809
http://dx.doi.org/10.2147/OPTH.S81061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404873/
https://www.ncbi.nlm.nih.gov/pubmed/25931809
http://dx.doi.org/10.2147/OPTH.S81061

Ejemplares similares